公开(公告)号：ZA9000072B

公开(公告)日：1990-10-31

申请号：ZA9000072

申请日：1990-01-19

Applicant: BASF AG ,  LOHMANN THERAPIE SYST LTS

Inventor： BAUS ULF ,  MUELLER WALTER ,  ULF BAUS ,  WALTER MUELLER ,  KINDEL HEINRICH ,  REUTHER WOLFGANG ,  WOLFGANG REUTHER ,  HEINRICH KINDEL

IPC: A61F20060101 ,  A61K20060101 ,  A61L20060101 ,  C07D20060101 ,  A61L ,  C07D ,  A61F ,  A61K

公开(公告)号：DE10022856A1

公开(公告)日：2001-11-15

申请号：DE10022856

申请日：2000-05-10

Applicant: BASF AG

Inventor： HAEHNLEIN WOLFGANG ,  KRAEMER KLAUS ,  HASSELWANDER OLIVER ,  MUELLER WALTER ,  ECKERT GUENTHER P

IPC: A61K31/385 ,  A61K31/519 ,  C07D339/04 ,  A61K31/7076 ,  A61K45/00 ,  A61P25/00 ,  A61P25/24 ,  A61P25/28 ,  C07D475/04 ,  C07H19/16 ,  A61K31/381

Abstract: The use of lipoic acid (I) (or its derivative or salt) is claimed for the preparation of a medicament for the C1 donor (II)-supported treatment of central nervous system disorders; and the use of (II) is claimed for the preparation of a medicament for the (I)-supported treatment of central nervous system disorders. Independent claims are included for the following: (i) a composition containing (I) (or its salt or derivative), (II), optionally further active agents and a formulation base; and (ii) a commercial package including at least one composition containing (I) (or its salt or derivative) and/or (II), together with instructions for the therapeutic use of (I) in combination with (II).

公开(公告)号：ZA9072B

公开(公告)日：1990-10-31

申请号：ZA9072

申请日：1990-01-19

Applicant: BASF AG ,  LOHMANN THERAPIE SYST LTS

Inventor： BAUS ULF ,  MUELLER WALTER ,  ULF BAUS ,  WALTER MUELLER ,  KINDEL HEINRICH ,  REUTHER WOLFGANG ,  WOLFGANG REUTHER ,  HEINRICH KINDEL

IPC: A61F20060101 ,  A61K20060101 ,  A61L20060101 ,  C07D20060101 ,  A61L ,  C07D ,  A61F ,  A61K